The nation of Zimbabwe has rejected a significant US health deal worth $367m (272 million pounds) spanning five years over Washington's insistence on confidential data.
The decision came to light after a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "skewed".
A government spokesman has since stated that the United States was requesting biological samples for scientific study and commercial purposes while was not willing to guarantee the benefits from future vaccines.
"We will now turn to the difficult and regrettable task of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for further talks to reach a agreement acceptable to both sides so the country's vital HIV programme can proceed.
Broader Context
This rejection follows a comparable case in Kenya, where a court suspended a related health funding agreement after legal challenges were raised about the security of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and accountability.
According to reports, Sixteen nations in Africa have to date signed similar health pacts, constituting more than $18.3bn in new funding.
Details of the Rejected Agreement
The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy via US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"Put simply, our country would supply the raw materials for scientific discovery with no assurance that the final treatments would be available to our citizens if a future health crisis emerge."
National Interest and Global Health
Mangwana further said that the American exit from the global health body and its pursuit of one-on-one health agreements were undermining systems previously established through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with future pandemics.
"This system is intended to ensure that when a nation contributes its data, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome continued discussions with our US partners on how subsequent collaboration could be structured in a way that honours the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but urged that talks must proceed considering a large portion of the nation's Aids initiatives were funded by external financing.
"In cases where specific concerns exist, including those involving data governance or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," the group added.
The halted deal highlights the complex debate between accepting vital foreign assistance and protecting local interests in an increasingly interconnected world.